Screener
Altimmune ALT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Altimmune’s reported figures.
The source filing: Altimmune’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326190-26-000040
FAQ
- What is Altimmune's free cash flow?
- Altimmune (ALT) reported free cash flow of -$20.96M in Q1 2026.
- What is the long-term trend for Altimmune's free cash flow?
- Over 2 years (2021 to 2023), Altimmune's free cash flow has grown at a -8.4% compound annual growth rate (CAGR), from -$90.36M to -$75.86M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Altimmune's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude